Skip to main content

Table 3 Prevalence of MS haplotypes between different island groups

From: Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands

Country

Province

Prevalence (%)

H1

H2

H3

H4

H5

H6

Solomon Islands

Temotu

0.0

0.0

76.5

20.6

2.9

0.0

Malaita

7.1

0.0

71.4

14.3

0.0

7.1

Vanuatu

Tafea

75.0

25.0

0.0

0.0

0.0

0.0